Subconjunctival injection of novel antioxidant nanoparticles inhibits neovascularization after corneal injury

20260 citationsJournal Article

Authors

Jilin Zhou · Xuzhou Medical College

Shuyi Hou · Xuzhou Medical College

Xing Wang · Xuzhou Medical College

Lin Zhu · Xuzhou Medical College

Zefeng Kang · China Academy of Traditional Chinese Medicine Hospital of Ophthalmology

Kai Xing · Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital

Jun Zhang

Abstract

The administration of BP@CS nanoparticles for sustained ROS regulation through local subconjunctival injection represents a new approach to the treatment of pathological corneal neovascularization.

Topics & Keywords

Corneal Surgery and Treatments Advanced Nanomaterials in Catalysis Advanced Drug Delivery Systems

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Nanomedicine

DOI: 10.1080/17435889.2026.2647022

Field-Weighted Citation Impact: 0.00